December 9, 2014

Endexx Contributes to Diabetic Neuropathy Case Study

Yahoo! Finance
Endexx Corporation (OTC PINK: EDXC) announced today that it is providing its CBD (Cannabidiol) starter kit (M3Vape) to a voluntary patient study utilizing industrial hemp oil that is rich in CBD/CBDa, as an application to potentially alleviate symptoms arising from diabetic neuropathy. Thirteen diabetic patients suffering from neuropathy in Missouri began a 30 day voluntary study in late November under the oversight of Dr. Daniel Kiddy, DPM. Dr. Kiddy stated, "The main objective for this short study is to simply see if pain is decreased or eliminated. We are also monitoring if the proprioception and sharp and dull sensation are improved.";_ylt=AwrBEiTQbYdUhV8A50LQtDMD

No comments:

Post a Comment